Clinical Study of Mitoxantrone Hydrochloride Liposome Injection vs. Chidamide in Patients With Relapsed/Refractory PTCL

Clinical trial NCT04668690 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04668690
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Peripheral T Cell Lymphoma

Start date: 2021-04-13
Primary completion: 2027-12-30
Enrollment: 193

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.